I-Mab (IMAB)
USD 0.86
(0.97%)
USD 0.86
(0.97%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 133.87 Million CNY | 78.53% |
| 2022 | 74.98 Million CNY | -33.32% |
| 2021 | 112.45 Million CNY | 726.88% |
| 2020 | 13.6 Million CNY | -89.74% |
| 2019 | 132.49 Million CNY | -9.88% |
| 2018 | 147.02 Million CNY | -30.98% |
| 2017 | 213 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 28.76 Million CNY | 0.0% |
| 2023 FY | 133.87 Million CNY | 78.53% |
| 2023 Q3 | 53.06 Million CNY | -31.7% |
| 2023 Q2 | 77.69 Million CNY | 54.24% |
| 2023 Q1 | 50.37 Million CNY | -32.82% |
| 2023 Q4 | 133.87 Million CNY | 152.26% |
| 2022 FY | 74.98 Million CNY | -33.32% |
| 2022 Q3 | 51.02 Million CNY | -50.86% |
| 2022 Q1 | 61.3 Million CNY | -45.49% |
| 2022 Q2 | 103.82 Million CNY | 69.37% |
| 2022 Q4 | 74.98 Million CNY | 46.96% |
| 2021 Q1 | 31.24 Million CNY | 129.74% |
| 2021 FY | 112.45 Million CNY | 726.88% |
| 2021 Q4 | 112.45 Million CNY | 37.5% |
| 2021 Q2 | 41.14 Million CNY | 31.67% |
| 2021 Q3 | 81.78 Million CNY | 98.79% |
| 2020 Q4 | 13.6 Million CNY | -82.55% |
| 2020 Q3 | 77.94 Million CNY | -7.86% |
| 2020 Q2 | 84.59 Million CNY | 10.74% |
| 2020 Q1 | 76.39 Million CNY | -42.34% |
| 2020 FY | 13.6 Million CNY | -89.74% |
| 2019 Q3 | 131.29 Million CNY | 1.62% |
| 2019 Q2 | 129.2 Million CNY | 4.47% |
| 2019 Q1 | 123.67 Million CNY | -15.88% |
| 2019 Q4 | 132.49 Million CNY | 0.91% |
| 2019 FY | 132.49 Million CNY | -9.88% |
| 2018 Q1 | - CNY | 0.0% |
| 2018 FY | 147.02 Million CNY | -30.98% |
| 2018 Q4 | 147.02 Million CNY | 0.0% |
| 2017 FY | 213 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 41.589% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -194.16% |
| Viracta Therapeutics, Inc. | 25.55 Million USD | -423.838% |
| AbCellera Biologics Inc. | 77.38 Million USD | -73.006% |
| Agenus Inc. | 350.24 Million USD | 61.778% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -28.498% |
| Aptorum Group Limited | 3.36 Million USD | -3881.445% |
| Bicycle Therapeutics plc | 44.95 Million USD | -197.785% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -32.045% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -88.616% |
| Chimerix, Inc. | 2.14 Million USD | -6144.03% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -541.02% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -369.052% |
| CRISPR Therapeutics AG | 238.63 Million USD | 43.9% |
| Dyadic International, Inc. | 136.92 Thousand USD | -97667.456% |
| Elevation Oncology, Inc. | 30.13 Million USD | -344.211% |
| Fortress Biotech, Inc. | 88.59 Million USD | -51.111% |
| Fortress Biotech, Inc. | 88.59 Million USD | -51.111% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -16460.078% |
| Structure Therapeutics Inc. | 5.45 Million USD | -2355.015% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -242575.61% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -21422.726% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 36.294% |
| Innoviva, Inc. | 449.07 Million USD | 70.189% |
| IO Biotech, Inc. | 2.49 Million USD | -5267.763% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -826.835% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -2071.484% |
| ContextLogic Inc. | 6 Million USD | -2131.2% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -14.232% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Onconetix, Inc. | 9.88 Million USD | -1254.189% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -41998.113% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -1648.27% |
| Vaxcyte, Inc. | 29.22 Million USD | -358.089% |
| Pharming Group N.V. | 171.54 Million USD | 21.961% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1258.831% |
| Seer, Inc. | 28.25 Million USD | -373.732% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -251.333% |
| Acelyrin, Inc. | 1.19 Million USD | -11112.06% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -46119.657% |
| Summit Therapeutics Inc. | 106.09 Million USD | -26.176% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -8087.89% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -2056.443% |
| Senti Biosciences, Inc. | 37.66 Million USD | -255.419% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -1858.625% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -132446.535% |
| TG Therapeutics, Inc. | 110.79 Million USD | -20.829% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -96.207% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -6214.717% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -695.437% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -14676.159% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -1805.923% |
| eFFECTOR Therapeutics, Inc. | 19.44 Million USD | -588.465% |
| Sorrento Therapeutics, Inc. | 134.5 Million USD | 0.47% |
| TRACON Pharmaceuticals, Inc. | 968 Thousand USD | -13729.752% |
| Vaxxinity, Inc. | 15.16 Million USD | -782.595% |
| ADMA Biologics, Inc. | 141.41 Million USD | 5.336% |
| Alkermes plc | 290.73 Million USD | 53.953% |
| Ardelyx, Inc. | 55.98 Million USD | -139.134% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -16.238% |
| Opthea Limited | 200.62 Million USD | 33.274% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -166556.707% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -1941.043% |
| MiMedx Group, Inc. | 48.09 Million USD | -178.326% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -276.518% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | 3.71% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -527.594% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -7998.73% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 95.01% |
| AlloVir, Inc. | 27.42 Million USD | -388.067% |
| AnaptysBio, Inc. | 17.81 Million USD | -651.499% |
| ChromaDex Corporation | 3.27 Million USD | -3985.2% |
| Clearside Biomedical, Inc. | 43 Million USD | -211.323% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -387.073% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -29.3% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -931.689% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -28083.579% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -56995.334% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -29611.633% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -115.662% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -23594.159% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -316.813% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -4561.281% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -2354.115% |
| Geron Corporation | 85.89 Million USD | -55.848% |
| Incyte Corporation | 38.28 Million USD | -249.654% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -84629.114% |
| Jaguar Health, Inc. | 35.86 Million USD | -273.318% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Novavax, Inc. | 280.63 Million USD | 52.297% |
| NextCure, Inc. | 6.6 Million USD | -1926.828% |
| Aridis Pharmaceuticals, Inc. | 6.13 Million USD | -2083.883% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -21.307% |
| Molecular Templates, Inc. | 12.23 Million USD | -994.62% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| PDS Biotechnology Corporation | 23.85 Million USD | -461.27% |
| Precigen, Inc. | 7.09 Million USD | -1786.318% |
| PureTech Health plc | 25.51 Million USD | -424.741% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -7835.507% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -120.987% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -62457.009% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -44418.047% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -7624.87% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -3663.621% |
| Precision BioSciences, Inc. | 31.26 Million USD | -328.144% |
| GT Biopharma, Inc. | 58 Thousand USD | -230713.793% |
| ImmuCell Corporation | 11.96 Million USD | -1018.461% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -445.481% |
| Mesoblast Limited | 118.92 Million USD | -12.57% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -434.59% |
| Aptose Biosciences Inc. | 1 Million USD | -13157.2% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -1546480.407% |
| Soligenix, Inc. | 3.49 Million USD | -3730.867% |
| Century Therapeutics, Inc. | 48.17 Million USD | -177.91% |
| Kura Oncology, Inc. | 17.2 Million USD | -678.326% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -44.831% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -6126.605% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -858.008% |
| Autolus Therapeutics plc | 52.96 Million USD | -152.746% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -2347.833% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -219.939% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 41.651% |
| GRI Bio, Inc. | 14 Thousand USD | -956128.571% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -977.527% |
| IGM Biosciences, Inc. | 40.5 Million USD | -230.499% |
| INmune Bio, Inc. | 10.43 Million USD | -1182.667% |
| Heron Therapeutics, Inc. | 179.62 Million USD | 25.473% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2166.305% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -163798.139% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -16090.72% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -158.565% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -129.701% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -131.324% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 72.159% |
| Verastem, Inc. | 41.55 Million USD | -222.141% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -2379.111% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1077.207% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1264.231% |
| Histogen Inc. | 4.62 Million USD | -2796.408% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 3.37 Million USD | -3861.882% |
| Organovo Holdings, Inc. | 1.39 Million USD | -9503.443% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 46 Million USD | -191.015% |
| Panbela Therapeutics, Inc. | 5.19 Million USD | -2477.436% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -530.312% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -626935.129% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -58.264% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -63947.46% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -343.05% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -82375.65% |
| Apollomics, Inc. | 4.66 Million USD | -2772.173% |
| Amarin Corporation plc | 8.73 Million USD | -1432.242% |
| Turnstone Biologics Corp. | 3.21 Million USD | -4065.277% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -58.103% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -54099.19% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -37.154% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | 29.52% |
| Better Therapeutics, Inc. | 14.88 Million USD | -799.677% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -337.29% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -20.684% |
| NLS Pharmaceutics AG | 1.63 Million USD | -8094.175% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -27.771% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4705.169% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -273834.929% |
| Avid Bioservices, Inc. | 207.83 Million USD | 35.587% |
| Insmed Incorporated | 1.2 Billion USD | 88.881% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.71 Million USD | -1894.814% |
| OmniAb, Inc. | 25.56 Million USD | -423.735% |
| Alector, Inc. | 38.91 Million USD | -243.985% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 37.424% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 15.15 Million USD | -783.585% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 72.019% |
| Aura Biosciences, Inc. | 19.55 Million USD | -584.522% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -111.933% |
| Immunic, Inc. | 1.33 Million USD | -9935.382% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -321.883% |
| Veracyte, Inc. | 12.63 Million USD | -959.952% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 79.24% |
| FibroGen, Inc. | 170.45 Million USD | 21.462% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1374.199% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -65552.172% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 97.691% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -361716.216% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -3059.594% |
| Galecto, Inc. | 249 Thousand USD | -53663.855% |
| Calithera Biosciences, Inc. | 1.66 Million USD | -7935.534% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 92.022% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -1729.602% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -2380.489% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -4705.169% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -398.017% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -197.012% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -9334.249% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -195.941% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -210.111% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -177.576% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 84.226% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -12930.199% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1122.017% |
| NexImmune, Inc. | 68.8 Thousand USD | -194455.945% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -943059.081% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 95.047% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -34050.846% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -1838.488% |
| Ainos, Inc. | 5.96 Million USD | -2144.835% |
| Pluri Inc. | 29.61 Million USD | -352.087% |
| Prothena Corporation plc | 11.83 Million USD | -1031.153% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -430.501% |
| Celularity Inc. | 65.41 Million USD | -104.644% |
| Rallybio Corporation | 392 Thousand USD | -34051.02% |
| Cue Biopharma, Inc. | 14.69 Million USD | -811.004% |
| MeiraGTx Holdings plc | 89.26 Million USD | -49.973% |
| Omeros Corporation | 338.28 Million USD | 60.426% |
| Humacyte, Inc. | 58.1 Million USD | -130.393% |
| Immunocore Holdings plc | 84.03 Million USD | -59.311% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -7124.609% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -2644.966% |
| Blueprint Medicines Corporation | 774.12 Million USD | 82.707% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -2567.836% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -116.558% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -28.604% |
| Pulmatrix, Inc. | 8.75 Million USD | -1428.917% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -1835.406% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -866.585% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -16.061% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -324.344% |
| Cytokinetics, Incorporated | 755.77 Million USD | 82.287% |
| Eloxx Pharmaceuticals, Inc. | 13.38 Million USD | -900.239% |
| Nutriband Inc. | 241.28 Thousand USD | -55382.935% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -2348.729% |
| Vor Biopharma Inc. | 35.66 Million USD | -275.412% |
| Roivant Sciences Ltd. | 499.74 Million USD | 73.212% |
| Evogene Ltd. | 1.13 Million USD | -11663.796% |
| ProKidney Corp. | 4.41 Million USD | -2933.583% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -10819.413% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 92.305% |
| CorMedix Inc. | 667.63 Thousand USD | -19951.765% |
| BioLineRx Ltd. | 11.59 Million USD | -1054.965% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -243.967% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -86.433% |
| Atai Life Sciences N.V. | 16.47 Million USD | -712.527% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -5361.943% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -19732.889% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -192.469% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -205856.923% |
| MediciNova, Inc. | 215.92 Thousand USD | -61899.018% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -5265.611% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -10516.101% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 28.169% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1200.233% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 67.744% |
| Mereo BioPharma Group plc | 5.95 Million USD | -2149.194% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -3629.025% |
| Absci Corporation | 15.95 Million USD | -738.955% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1361.325% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -812.494% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -388.317% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -992.119% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -970.462% |
| Allakos Inc. | 41.46 Million USD | -222.855% |
| Imunon, Inc. | 1.62 Million USD | -8139.727% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1137.15% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -88556.954% |
| BioAtla, Inc. | 2.46 Million USD | -5341.951% |
| NLS Pharmaceutics AG | 1.63 Million USD | -8094.175% |
| Bio-Path Holdings, Inc. | 113 Thousand USD | -118370.796% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -40.739% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -2313.848% |
| XOMA Corporation | 124.45 Million USD | -7.571% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -607.083% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -210.126% |
| aTyr Pharma, Inc. | 15.09 Million USD | -786.863% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1101.939% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -414.042% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -536.032% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -38258.739% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -40903.023% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -8104.324% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 91.071% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -81545.697% |
| UroGen Pharma Ltd. | 100.21 Million USD | -33.586% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 26.745% |
| ZIVO Bioscience, Inc. | 346.34 Thousand USD | -38553.123% |
| Orgenesis Inc. | 22.62 Million USD | -491.804% |
| Entera Bio Ltd. | 390 Thousand USD | -34226.154% |
| GH Research PLC | 343 Thousand USD | -38929.738% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -43792.459% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -13658.684% |
| Xencor, Inc. | 83.43 Million USD | -60.453% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -77429.203% |
| Replimune Group, Inc. | 75.86 Million USD | -76.452% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -10835.236% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1323.564% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -81545.697% |
| Portage Biotech Inc. | 47 Thousand USD | -284734.043% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -10516.101% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -5438.767% |
| OncoCyte Corporation | 2.86 Million USD | -4566.155% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -10204.06% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -88819.59% |
| Purple Biotech Ltd. | 351 Thousand USD | -38040.171% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -4137.797% |
| scPharmaceuticals Inc. | 40.26 Million USD | -232.444% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 51.19 Million USD | -161.505% |
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -94176.056% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -2459.205% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -400.681% |
| Curis, Inc. | 2.79 Million USD | -4691.41% |
| Daré Bioscience, Inc. | 5.31 Million USD | -2417.269% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -6166.099% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -700.143% |
| BeiGene, Ltd. | 930.18 Million USD | 85.608% |
| Kiromic BioPharma, Inc. | 15.54 Million USD | -761.329% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -52.224% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -11632.866% |
| Erasca, Inc. | 55.85 Million USD | -139.661% |
| bluebird bio, Inc. | 330.32 Million USD | 59.473% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 88.193% |
| DBV Technologies S.A. | 14.38 Million USD | -830.895% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -5250.6% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -2782.687% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 66.928% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -190.78% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -2804.578% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -5166.404% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -610.083% |
| MacroGenics, Inc. | 33.97 Million USD | -294.077% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 20.92 Million USD | -539.801% |
| Prime Medicine, Inc. | 13.63 Million USD | -881.97% |
| Aditxt, Inc. | 18.21 Million USD | -634.834% |
| Adagene Inc. | 22.3 Million USD | -500.138% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -774.809% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 78.089% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -559.695% |
| SciSparc Ltd. | 76 Thousand USD | -176047.368% |
| Vericel Corporation | 88.14 Million USD | -51.88% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -63.225% |
| Generation Bio Co. | 97.89 Million USD | -36.752% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -40590.578% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -429.18% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 34.987% |
| Invivyd, Inc. | 2.16 Million USD | -6083.464% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -150.387% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -3799056.008% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -2315.154% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -212395.238% |
| 2seventy bio, Inc. | 256.67 Million USD | 47.843% |
| Clene Inc. | 32.16 Million USD | -316.256% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -2285.394% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -5998.952% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -164.193% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -27717.847% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 30.705% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 30.12 Million USD | -344.374% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -678.461% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -7.493% |
| Evaxion Biotech A/S | 10.86 Million USD | -1131.61% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -60.539% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -78.718% |
| Trevena, Inc. | 35.23 Million USD | -279.962% |
| Surrozen, Inc. | 3.37 Million USD | -3861.882% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -1960.837% |
| Cingulate Inc. | 3.13 Million USD | -4170.104% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -326417.073% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -396.006% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -26626.133% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -22100.995% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -134.022% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -28689.677% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -373.514% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -562.11% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -8509.132% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -10524.762% |
| Statera Biopharma, Inc. | 16.26 Million USD | -723.263% |
| ImmunityBio, Inc. | 883.67 Million USD | 84.851% |
| Korro Bio, Inc. | 33.2 Million USD | -303.144% |
| Kineta, Inc. | 1.31 Million USD | -10064.92% |
| BioVie Inc. | 6.11 Million USD | -2090.512% |
| Codexis, Inc. | 22.36 Million USD | -498.605% |
| Celularity Inc. | 65.41 Million USD | -104.644% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -158.8% |
| Celcuity Inc. | 37.44 Million USD | -257.504% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -59584.351% |
| Cibus, Inc. | 24.62 Million USD | -443.731% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -34853.525% |
| IN8bio, Inc. | 4.89 Million USD | -2635.99% |
| Kodiak Sciences Inc. | 181.63 Million USD | 26.295% |
| Annexon, Inc. | 31.35 Million USD | -326.956% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -78.41% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -5616.14% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -3329.977% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 90.79% |
| Eyenovia, Inc. | 16.1 Million USD | -731.103% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -20.075% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -13491.066% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1068.473% |
| Arcellx, Inc. | 97.62 Million USD | -37.129% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -6129.502% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -404.93% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -4215.667% |
| Moolec Science SA | 2.64 Million USD | -4960.77% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -369.941% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -2020.577% |
| Royalty Pharma plc | 6.13 Billion USD | 97.818% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -5473.356% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -116053.886% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -295.72% |
| Humacyte, Inc. | 58.1 Million USD | -130.393% |
| 89bio, Inc. | 27.1 Million USD | -393.847% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -907.617% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -5214.49% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -9905.381% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -26.218% |
| Notable Labs, Ltd. | 2.04 Million USD | -6433.529% |
| Liquidia Corporation | 3.5 Million USD | -3721.639% |
| Mustang Bio, Inc. | 2.49 Million USD | -5259.167% |
| Immunovant, Inc. | 138 Thousand USD | -96908.696% |
| Quantum-Si incorporated | 15.3 Million USD | -774.809% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1435.053% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -33368.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -149.259% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -163798.139% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1127.846% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -63500.473% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -65846.798% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -547.945% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -33118.859% |
| PepGen Inc. | 20.1 Million USD | -565.897% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -23222.648% |
| United Therapeutics Corporation | 700 Million USD | 80.875% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 26.26 Million USD | -409.697% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.46 Million USD | -2899.624% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 886 Thousand USD | -15009.707% |
| XOMA Corporation | 124.45 Million USD | -7.571% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -48758.394% |
| Bionomics Limited | 239.61 Million USD | 44.131% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -6481.714% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -908.376% |
| uniQure N.V. | 138.4 Million USD | 3.278% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -56.717% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -12872.093% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -13491.066% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1374.199% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -7562.965% |
| Altimmune, Inc. | 671 Thousand USD | -19851.118% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 69.92% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -908.376% |
| Compugen Ltd. | 1.35 Million USD | -9809.104% |
| Peak Bio, Inc. | 10.72 Million USD | -1148.596% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -213.034% |
| Benitec Biopharma Inc. | 284 Thousand USD | -47038.028% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -58.325% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -572.014% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 11.77 Million USD | -1036.531% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -46.375% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -572.014% |
| Instil Bio, Inc. | 86.05 Million USD | -55.567% |
| argenx SE | 20 Million USD | -569.36% |
| Immunome, Inc. | 1.65 Million USD | -8013.455% |
| Verona Pharma plc | 51.32 Million USD | -160.812% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1269.114% |
| Shattuck Labs, Inc. | 4.2 Million USD | -3085.911% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -36881.215% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -3101.913% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -22784.103% |
| Moolec Science SA | 2.64 Million USD | -4960.77% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -343.149% |
| Design Therapeutics, Inc. | 3.05 Million USD | -4289.246% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -50996.183% |
| NeurAxis, Inc. | 224.26 Thousand USD | -59594.997% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -840.905% |
| Lumos Pharma, Inc. | 6.58 Million USD | -1932.984% |
| Achilles Therapeutics plc | 4.61 Million USD | -2800.802% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1269.114% |
| 180 Life Sciences Corp. | 1.32 Million USD | -10041.288% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -683.788% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -8509.132% |
| Nutriband Inc. | 241.28 Thousand USD | -55382.935% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1210.8% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -16107.264% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 64.179% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -344.772% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -3520.25% |
| Palisade Bio, Inc. | 369 Thousand USD | -36179.675% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -32158.313% |
| Beam Therapeutics Inc. | 173.17 Million USD | 22.695% |
| Neurogene Inc. | 16.25 Million USD | -723.574% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 56.555% |
| AEON Biopharma, Inc. | 278 Thousand USD | -48055.396% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -39861.791% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -125141.601% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -76.468% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -119.078% |
| Athira Pharma, Inc. | 1.58 Million USD | -8346.183% |
| Vaccinex, Inc. | 247 Thousand USD | -54099.19% |
| HCW Biologics Inc. | 6.45 Million USD | -1974.963% |
| XOMA Corporation | 124.45 Million USD | -7.571% |
| Nektar Therapeutics | 230.4 Million USD | 41.896% |
| Arvinas, Inc. | 3.4 Million USD | -3837.412% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -8104.324% |
| Merus N.V. | 12.16 Million USD | -1000.74% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -4.239% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -869.104% |
| Rezolute, Inc. | 2.22 Million USD | -5908.618% |
| Clene Inc. | 32.16 Million USD | -316.256% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -76375.125% |
| BeyondSpring Inc. | 3.99 Million USD | -3250.989% |
| Synlogic, Inc. | 17.27 Million USD | -674.946% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -10197.846% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -382391.429% |
| Peak Bio, Inc. | 10.72 Million USD | -1148.596% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -157.828% |
| Krystal Biotech, Inc. | 8.09 Million USD | -1553.966% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | 24.373% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -1797.01% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -97907.233% |
| MannKind Corporation | 382.37 Million USD | 64.99% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1146.713% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -32631.54% |
| Gossamer Bio, Inc. | 212.46 Million USD | 36.991% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -76837.931% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1361.325% |
| Legend Biotech Corporation | 328.67 Million USD | 59.269% |
| Mural Oncology plc | 15 Million USD | -791.945% |
| Biora Therapeutics, Inc. | 47.42 Million USD | -182.276% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 2.1 Million USD | -6271.823% |
| Champions Oncology, Inc. | 7.43 Million USD | -1701.777% |
| REGENXBIO Inc. | 89.29 Million USD | -49.929% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -15563.095% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -24109.106% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -2372.7% |
| Vaxart, Inc. | 26.51 Million USD | -404.911% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -755.01% |
| Cellectis S.A. | 92.85 Million USD | -44.176% |
| Longeveron Inc. | 2.04 Million USD | -6459.138% |
| Repare Therapeutics Inc. | 3.41 Million USD | -3825.865% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 90.416% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -187.328% |
| Revolution Medicines, Inc. | 87.94 Million USD | -52.224% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -77282.659% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -3286.592% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -42130.915% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -76398.286% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 83.44% |
| Denali Therapeutics Inc. | 52.24 Million USD | -156.258% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -829.314% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -9643.231% |
| Cingulate Inc. | 3.13 Million USD | -4170.104% |
| Passage Bio, Inc. | 26.29 Million USD | -409.135% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -1908.582% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -32711.765% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -14874.497% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -551.097% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -10524.762% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -5361.664% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -4186.647% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -16407.028% |
| OmniAb, Inc. | 25.56 Million USD | -423.735% |
| Anew Medical, Inc. | 1.6 Million USD | -8240.935% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -352.532% |
| Lipocine Inc. | 17.16 Thousand USD | -779767.179% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1050.301% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -286.6% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2166.305% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -134.152% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -65846.798% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -2491.907% |
| Ocugen, Inc. | 6.94 Million USD | -1828.713% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -847.498% |
| Q32 Bio Inc. | 1.31 Million USD | -10057.208% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -19821.429% |
| Alumis Inc. Common Stock | 32.58 Million USD | -310.902% |
| Equillium, Inc. | 824 Thousand USD | -16146.602% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1374.524% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -44404.431% |
| Galera Therapeutics, Inc. | 152.29 Million USD | 12.099% |
| Evelo Biosciences, Inc. | 51.13 Million USD | -161.786% |
| Comera Life Sciences Holdings, Inc. | 775.04 Thousand USD | -17172.737% |
| Dominari Holdings Inc. | 3.02 Million USD | -4321.136% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -141582.983% |
| vTv Therapeutics Inc. | 529 Thousand USD | -25206.616% |
| Bio-Techne Corporation | 419.53 Million USD | 68.091% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -85.944% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 30.839% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -692.705% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -488.138% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -2109.838% |
| Nkarta, Inc. | 88.33 Million USD | -51.543% |
| BioCardia, Inc. | 1.31 Million USD | -10080.38% |
| Iterum Therapeutics plc | 19.5 Million USD | -586.206% |